Novel Antimicrobial Biomaterials

显然，需要有新的材料来驱赶细菌。与生物材料相关的感染在人类健康和福祉方面造成了高昂的成本，但这种感染也增加了医疗保健系统的负担，因为它延长了住院时间，并显著提高了成本。对于重症监护病房的患者来说，与导管相关的血流感染的成本约为5万美元。如果将所有医疗设备都考虑在内，那么相关感染的成本约为200亿美元。这里提出的技术有可能降低与生物材料相关的感染率，改善医疗保健，降低医疗保健成本。

There is a clear need for new materials that repel bacteria. Infections associated with biomaterials incur a high cost in terms of human health and well being, but such infections also increase the burden on the health care system by extending hospital stays and significantly elevating costs. The cost of a catheter-related blood stream infection is around $50,000 for patients in intensive care units. If all medical devices are considered, the cost of related infections is then approximately $20 billion. The technology proposed here has the potential to reduce biomaterial related infection rates, improve health care and reduce health care costs.